Cynata Therapeutics Limited (FRA:51S)

Cynata Therapeutics Revenue

In the fiscal year ending June 30, 2025, Cynata Therapeutics had annual revenue of 1.89M AUD, down -18.59%. Cynata Therapeutics had revenue of -84.99K in the half year ending June 30, 2025.

• Revenue: 1.89M AUD
• Revenue Growth: -18.59%
• P/S Ratio: 31.15
• Revenue / Employee: 942.57K AUD
• Employees: 2
• Market Cap: 32.79M EUR

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	1.89M	-430.50K	-18.59%
Jun 30, 2024	2.32M	661.33K	39.98%
Jun 30, 2023	1.65M	-6.12M	-78.71%
Jun 30, 2022	7.77M	6.22M	402.60%
Jun 30, 2021	1.55M	-5.47M	-77.95%